Understanding XPOVIO(Selinexor), the first and only approved oral nuclear export inhibitor that blocks XPO1
Presented By: Kathleen Clifford, NP
St. Luke's Mountain States Tumor Institute
Date and Time: February 18, 2020 5:30pm
Location: Artichoke Café
424 Central Ave. SE
Albuquerque, NM 87102
RVSP: 866-914-9069
KaryopharmRSVP@pw.veeva.com
Tanya Granados
505-401-4411 tgranados@karyopharm.com
KAR0000535 please reference this number during registration.